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Antibiotic production is regulated by numerous signals, including the so-called
bacterial hormones found in antibiotic producing organisms such as Strepto-
myces. These signals, the g-butyrolactones, are produced in very small quantities,
which has hindered their structural elucidation and made it difficult to assess
whether they are being produced. In this chapter, we describe a rapid small-scale
extraction method from either solid or liquid cultures in scales of one plate or
50 ml of medium. Also described is a bioassay to detect the g-butyrolactones
by determining either the production of pigmented antibiotic of Streptomyces
coelicolor or kanamycin resistant growth on addition of the g-butyrolactones.
We also describe some insights into the identification of the g-butyrolactone
receptor and its targets and also the gel retardation conditions with three
differently labeled probes.vier Inc.
reserved.
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144 Nai-Hua Hsiao et al.1. Introduction
Most secondary metabolites (including antibiotics) are the products of
complex biosynthetic pathways activated in the stationary phase or during
slow growth, which triggers the transition from primary to secondary
metabolism (Bibb, 2005). This switch is complex and poorly understood,
and involves many signals, including those by small signaling molecules
called g-butyrolactones. These signaling molecules, found mainly in Strep-
tomyces species, are considered to be ‘‘bacterial hormones’’ because they are
important in the regulation of antibiotic production and in some cases
morphological differentiation (Takano, 2006). The first g-butyrolactone,
A-factor, was identified from Streptomyces griseus in 1967 and was isolated as
a compound that could stimulate the production of streptomycin and
sporulation in a mutant defective in these characteristics (Khokhlov et al.,
1967) (Fig. 6.1). Subsequently, the group of Sueharu Horinouchi identified












































Figure 6.1 Chemical structures of the g-butyrolactones. SCB1, 2, and 3 are produced
by S. coelicolor; A-factor is produced by S. griseus;VB-A, B, C. D, and E are produced by
S. virginiae. Figure contributed byChristianHertweckwith permission.
g-Butyrolactone Extraction, Bioassay, and Gel Retardation Analysis 145synthesis of A-factor (Horinouchi et al., 1985) and also the pathway by
which A-factor regulates streptomycin production (Ohnishi et al., 1999).
Other g-butyrolactones and its receptor systems were identified in Strepto-
myces virginae (Yamada, 1999 review), Streptomyces lavendulae FRI-5 (Kitani
et al., 2008), and Streptomyces coelicolor (Takano et al., 2005), the model
organism for Streptomyces genetics.
The number of identified receptor homologues has more than tripled in
recent years with the analysis of antibiotic biosynthetic gene cluster
sequences, suggesting that the g-butyrolactone system may be a widespread
regulatory component in controlling antibiotic production in the genus
Streptomyces and in other actinomycetes (Takano, 2006).
These signaling molecules are produced only in minute concentrations,
making them challenging to purify. However, their activity in nanomolar
concentration is helpful in bioactivity assays, which can be performed with
small quantities of material. In all the systems that have been reported, the
g-butyrolactones have been detected by such bioassays. For example:
A-factor in S. griseus is extracted with chloroform and detected by measur-
ing the induction of streptomycin production on a solid culture of a non-A-
factor producing mutant, S. griseus HHI (Hara and Beppu, 1982); virginiae
butanolides (VBs) in Streptomyces virginiae are extracted with ethyl acetate
from acidified cell-free supernatants of cultures and detected by measuring
the production of virginiamycin in a liquid culture of an S. virginiae mutant
(Nihira et al., 1988); IM-2 in S. lavendulae FRI-5 is extracted in the same
way as VBs and detected by the induction of a blue pigment (Sato et al.,
1989).
To quickly assess whether g-butyrolactones are a regulatory component
in the antibiotics of choice, a large-scale purification or structural elucida-
tion is not the first preference. This chapter describes the rapid small-scale
extraction and detection of g-butyrolactones in S. coelicolor which will aid in
solving this problem. We also aim to aid identification of g-butyrolactone
receptors and their targets.2. Rapid Small-Scale g-Butyrolactone
Purification
Intracellularly produced g-butyrolactones are believed to diffuse pas-
sively out of the mycelium. In most protocols, liquid culture supernatants
are used for production. However, the amounts of g-butyrolactones
produced in liquid cultures vary with the growth of the mycelium and
extraction can be tedious. Therefore, we have developed a method using
plates of solid agar medium. Here, we describe extraction protocols for both
liquid and solid cultures.
146 Nai-Hua Hsiao et al.1. Grow the strain either on plates up to aerial mycelium formation or early
spore formation, or in liquid medium up to early stationary phase.
Note: Both minimal and rich media can be used in both cases; however,
the stability of the g-butyrolactones in rich media is much less than in a
defined medium and they must be extracted at an earlier time.
2. For plates, cut the agar into large pieces and place in a beaker. Add
30–40 ml ethyl acetate to cover the agar pieces, and shake gently.
Transfer the ethyl acetate into a rotary flask.
Note: Avoid breaking the agar into small pieces as this makes it difficult to
separate the agar from the solvent. Also, it is important to test the ethyl
acetate used for extraction beforehand as some ethyl acetate may already
have bioactivity.
3. For liquid cultures, add a 2–3-fold volume of ethyl acetate in a separation
flask. Shake 5–10 times, then separate the ethyl acetate phase from the
water phase and place the ethyl acetate phase in a rotary flask.
Note: If a small amount of second phase separates from the ethyl acetate
sample, remove it before evaporation. Normally, any second phase consists
of fatty acids which cannot be evaporated will affect the diffusion ability of
samples in the bioassay.
4. Evaporate all the ethyl acetate in a rotary evaporator and resuspend in
100% HPLC-grade methanol.
Note: From 3 plates or from 50 ml cultures, resuspend sample in 50 ml
of methanol.3. Antibiotic Bioassay
The classical approach for the bioassay of g-butyrolactones is the obser-
vation or measurement of induced antibiotic production from an indicator
strain in response to the compound of interest. Based on this concept, the
antibiotic bioassay in S. coelicolor detects early production of the pigmented
antibiotics, blue actinorhodin, and red prodiginines (Takano et al., 2000).
1. Prepare spore stocks of the antibiotic bioassay indicator strain S. coelicolor
M145 (Kieser et al., 2000). Determine viable counts and store spores at
20 C in 20% glycerol.
2. Prepare supplemented minimal media solid (SMMS) plates (20 ml agar/
plate; Takano et al., 2001).
Note: The source of the agar strongly affects the timing and production of
the pigmented antibiotics. Try to use only agar from the same company
and the same batch.
g-Butyrolactone Extraction, Bioassay, and Gel Retardation Analysis 1473. For each plate, add 1  107–108 M145 spores (so the plate is just about
confluent) in 60–100 ml of water. Using wet sterile cotton buds, spread
confluently onto the plates and dry in the laminar flow cabinet.
4. Spot a sample (<2 ml) in the middle of the plate and dry. Incubate plates
at 30 C, check them every 8–12 h and record the antibiotic production
by scanning the plates on a scanner (or take a photograph) (Fig. 6.2).
Note:
 Avoid dropping a sample before a plate is completely dry or dropping
more than 2 ml of the sample. If the sample volume is more than 2 ml,
spot in 2 ml aliquots several times after drying each time or concentrate
the sample before spotting.
 The extracted samples should be spotted onto the indicator plate
within 8 h of spreading, the sooner the better. No induction of the
pigmented antibiotics will be observed if the indicator is grown for
more than 8 h.
 The optimal amount of the positive control is 0.25 mg for the
g-butyrolactone SCB1. When using extracts made from S. coelicolor
M145, 20–30 ml out of the 50 ml of sample either from 50 ml liquid
cultures or from three plates should give bioactivity.
 To measure the approximate concentration of g-butyrolactones
isolated: for plates start the inoculum with the exact same number of
viable spore counts for each sample; for liquid cultures measure the
growth phase (by OD450 nm) convert into milligrams per dry weight
and also measure the volume of the supernatant; this amount then can
be used for comparison between samples.
 As seen in Fig. 6.2, the color may change depending on the amount of




Figure 6.2 An example of a typical bioassay. Extracts from solid plates of S. coelicolor
J1501and S. lividanswere spotted onto the indicator strain M145, then incubated for 36 h
at 30 C. The pigmented halos are the result of the butyrolactones stimulating
pigmented antibiotic production.
148 Nai-Hua Hsiao et al.4. Kanamycin Bioassay
The kanamycin bioassay was developed as an easy and direct method to
detect g-butyrolactone. It is based on the g-butyrolactone receptor, ScbR,
and its binding to the target DNA and the g-butyrolactones. ScbR represses
transcription of its own gene and that of cpkO, a pathway-specific regulatory
gene for the Cpk cluster, by binding to the promoter regions (Pawlik et al.,
2007; Takano et al., 2005). This repression is abolished by SCB1, resulting in
transcription of the target genes. Using these principles, a g-butyrolactone
detection plasmid, pTE134, was constructed which harbors scbR and its own
promoter region with the ScbR binding sites, together with the cpkO
promoter with the ScbR binding sites, fused to a promoterless-kanamycin
resistance gene (Fig. 6.3). pTE134, was transferred into S. coelicolor LW16
(scbA and scbR double deletion mutant) to obtain the kanamycin indicator
strain LW16/pTE134. LW16 was chosen as a host strain for the kanamycin
bioassay because it does not produce g-butyrolactones and it lacks scbR,
thus avoiding competition from endogenous ScbR. The kanamycin
bioassay indicator strain LW16/pTE134 is sensitive to kanamycin but

















Figure 6.3 Schematicmapof pTE134 used for the kanamycin bioassay. pTE134 has scbR
(open arrow) with its own promoter region, scbRp (black arrow) and a cpkO promoter,
cpkOp (black arrow) coupled with a promoterless kanamycin resistance gene (neo, solid
arrow). The light gray arrow indicates hyg (omega hygromycin resistance gene), the
deep gray arrow represents oriT (RP4 origin of single-stranded DNA transfer), the
hatched arrow represents int (phiC31 integrase), the shaded arrow indicates a partial
coding region (204 bp) of scbB and the attP site (phage phiC31 attP site) is indicated by
a vertical black line. Restriction sites used for cloning are indicated by black lines
(not allSacI andEcoRI sites are shownon themap).
g-Butyrolactone Extraction, Bioassay, and Gel Retardation Analysis 149and the kanamycin resistance gene is transcribed, rendering the indicator
strain kanamycin resistant (Hsiao et al., submitted for publication).
This assay was also tested for its ability to detect other butyrolactones
than the ones produced by S. coelicolor. Though the sensitivity is weaker than
for the native g-butyrolactones, with enough material spotted to the plates,
kanamycin resistance can be observed. Furthermore, g-butyrolactones have
been identified from those antibiotic producing Streptomyces strains which
were not known to produce these molecules using this assay (Hsiao et al.,
submitted for publication).
1. Prepare spore stocks of the kanamycin bioassay indicator strain LW16/
pTE134 and stock spores in 50–100 ml aliquots at –20 C in 20% glycerol.
Note: Because this indicator strain is unstable, spores need to be collected
from MS plates (Kieser et al., 2000) containing 50 mg/ml hygromycin, then
aliquoted. Avoid thawing and refreezing the spore stocks.
2. Prepare fresh DNAgar (Difco Nutrient Agar) plates containing kanamy-
cin at a final concentration 3–5 mg/ml (20 ml per plate).
Note: Because the cpkO promoter has very low activity (conferring
resistance to <10 mg/ml kanamycin), the concentration of kanamycin
should not be higher than 5 mg/ml (Fig. 6.4).
3. To each plate, add 2.6  106 spores of the indicator strain in about
60–100 ml of water. Using wet sterile cotton buds, spread confluently
onto the plates and dry.
4. Spot the extract or sample (<2 ml) in the middle of the plate and dry.
Incubate plates at 30 C, check them after 2–3 days and record the growth
by scanning the plates on a scanner. The kanamycin resistant colonies will
grow around the spot where the g-butyrolactones have diffused.50mg/ml
10mg/ml5mg/ml
25mg/ml
Figure 6.4 The kanamycin bioassay using different kanamycin concentrations in the
indicator media. 0.1 mg of chemically synthesized SCB1 was spotted onto lawns of
LW16/pTE134 (2.6106 spores) onDNAgar plates containing 5,10, 25, or 50 mg/ml kana-
mycin, respectively.The plateswere incubated at 30 C for 3 days.
1.48102
2.6106
Figure 6.5 The kanamycin bioassay using different amount of indicator strains. 0.1 mg
of chemically synthesized SCB1 was spotted onto lawns of LW16/pTE134 (2.6  106
or 1.48  107 spores) on DNAgar plates containing 5 mg/ml kanamycin, respectively.
The plateswere incubated at 30 C for 3 days.
150 Nai-Hua Hsiao et al.Note:
 Again avoid spotting a sample before a plate is completely dry or
spotting more than 2 ml of the sample. If the sample volume is more
than 2 ml, spot in 2 ml aliquots several times after drying each time or
concentrate the sample before spotting.
 The optimal amount of the positive control is 0.1 mg for SCB1 and
0.25 mg for A-factor. To enhance the density of the growth halo,
a larger amount of indicator spores and a smaller amount of kanamycin
in the indicator plate can be used (Figs. 6.4 and 6.5).5. Identification of g-Butyrolactone Receptors
Several groups have used different methods to identify the g-butyr-
olactone receptors. The first receptor to be identified was by Horinouchi
and co-workers using an A-factor affinity column and recovering
the receptor from the crude extract of S. griseus (Onaka et al., 1995).
The same technique was used to identify the g-butyrolactone receptors
from S. virginiae (Okamoto et al., 1995) and S. lavendulae FRI-5
(Ruengjitchatchawalya et al., 1995). Another approach was via PCR
using degenerate oligonucleotides to isolate the two receptor homologues
in S. coelicolor (Onaka et al., 1998). Interestingly, Onaka and co-workers
failed to identify ScbR with this approach. This may be due to the limited
homologous sequence information at the time.
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gene, ScbA, which lies divergent from the ScbR gene, using PCR (Takano
et al., 2001). In most of the g-butyrolactone systems identified (apart from
that in S. griseus) synthase and receptor genes are next to or very close to
each other. It is best to use this property and to identify the g-butyrolactone
synthase gene first using degenerate oligonucleotides or by an in silico
approach. The degenerate oligonucleotides should be designed near
the active sites we have identified by mutagenesis analysis, which also
correspond to the AfsA repeats (Hsiao et al., 2007).
Another approach is to use any sequence information available. These
g-butyrolactone receptors will resemble TetR repressors and may be found
especially concentrated close to antibiotic biosynthetic gene clusters. There
are usually several g-butyrolactone receptor homologues in one strain.
To determine the ‘‘real’’ receptor, the amino acid identity should be
more than 40% compared to the functionally proven g-butyrolactone
receptors, that is, ArpA, BarA, FarA, and ScbR. These proteins also will
have a pI of around 5–6 compared to the other ScbR homologues whose
pIs are much higher at around 9–11.6. Identification of the g-Butyrolactone
Receptor Targets
The first target to be identified was from the A-factor system by use
of the genomic SELEX (systematic evolution of ligands by exponential
enrichment) system (Ohnishi et al., 1999). This method uses purified
g-butyrolactone receptor in gel retardation assays on partially digested
chromosomal DNA to find the binding sites. Several groups have now
proposed the target sequences for the g-butyrolactone receptors (Folcher
et al., 2001; Kinoshita et al., 1999; Onaka and Horinouchi, 1997) (Fig. 6.6).
However, these sequences are not sufficiently conserved compared with the
identified targets for ScbR (Fig. 6.6).
We have used the properties of the TetR receptor family, which the
g-butyrolactone receptors resemble. TetR proteins regulate their own
genes and/or the adjacent gene. By using this property, gel retardation
was performed to identify one of the ScbR targets. To identify another
target of ScbR, microarray analysis was performed, which did not result in
the identification of a direct target but rather the downstream genes which
represent the Cpk antibiotic biosynthetic gene cluster. But doing so, the
direct target, a pathway-specific activator, for the Cpk cluster was identified.
Surprisingly, of the four targets of ScbR that we have identified, two, site R
and site OA, have 100% consensus sequences at 6 bp at each ends. While the
SiteA (scbA/R promoter region) GAAAAAAAACCGCTCTAGTCTGTATCTTAA
SiteOB (kasO promoter region)
SiteR (scbA/R promoter region)
SiteOA (kasO promoter region)
ScbR binding consensus
ArpA binding consensus































Figure 6.6 Consensus sequences of different g-butyrolactone receptors. The target
sequences found so far for ScbR and its consensus sequences in S. coelicolor are presented
on the top five lanes.The bottom three lanes are consensus sequences reported for the
different receptor proteins. ArpA: Onaka and Horinouchi (1997); BarA, FarA:
Kinoshita et al. (1999); SpbR: Folcher et al. (2001). Bold letters represent the conserved
base pairs in ScbRbinding sites.The base pairs in italic in siteA and siteOB represent the
conserved base pairs between these two sites.
152 Nai-Hua Hsiao et al.others, site A and site OB, only have 4 bp that are conserved with site R and
site OA. In contrast, within the pair, 11 bp are conserved out of 23 bp
(Fig. 6.6) (Takano et al., 2005).
To identify the g-butyrolactone receptor targets, first use the promoter
region itself, and also include the promoter region of the gene adjacent to it,
to perform a gel retardation assay with either a purified protein or a crude
extract. The activity of the protein is stabilized when the protein is still in
the crude extract and at a low concentration. As soon as the protein is
purified and concentrated, it tends to aggregate and will no longer be
suitable for any further experiments to analyze activity. Use the identified
target sequence to identify further targets in silico.7. Gel Retardation Assay to Detect Target
Sequences of the g-Butyrolactone Receptors
Gel retardation is not a new technique and can be found described in
many publications (e.g., Folcher et al., 2001; Kinoshita et al., 1999; Onaka and
Horinouchi, 1997). However, we have experience in using three differently
labeled g-butyrolactone receptor target DNA fragments, and have optimized
the technique for each probe using pure protein and crude extracts from
either Escherichia coli or Streptomyces.
g-Butyrolactone Extraction, Bioassay, and Gel Retardation Analysis 1537.1. Labeling of DNA fragments
7.1.1. Radio-labeled probes
1. The oligo was first labeled at the 50 ends by incubation of 50 pmol
of oligo, 5 ml of [g-32P]ATP (10 mCi/ml), 1 ml of 10 kinase buffer,
and 1 ml T4 nuclease kinase in a total volume of 50 ml incubated at 37 C
for 30 min–1 h. The reaction was stopped and cleaned by addition of 1
volume of phenol/chloroform with vortexing, then the phenol was
extracted by addition of either 1 vol of chloroform or ether, twice.
The oligo were precipitated using 100% EtOH with 3 M NaoAc and
1 mg of glycogen at 20 C preferably O/N. The mixture was spun at
4 C for 30 min, then the supernatant discarded, and the pellet air dried.
2. PCR was conducted using labeled- and unlabeled-oligos. 60 ng of tem-
plate, 50 pmol of both unlabeled- and labeled-oligos, 200 mM dNTP, 5%
DMSO, and PCR buffer (commercial) together with Taq polymerase
were incubated to amplify in a total volume of 100 ml. The PCR condi-
tions are: 95 C for 5 min, then 30 cycles of 95 C for 50 s, 55 C for 40 s,
72 C for 40 s, then extend at 72 C for 5 min. Five microliters of the
reaction was loaded on a gel to assure amplification. If extra bands are
amplified, the fragment of interest can be purified using a commercial
gel-extraction kit. The final volume should be eluted in 50 ml.
3. Gel retardation was conducted with 2.5 ng of labeled DNA (about
10 cpm), pure protein or 0–15 ml crude extract from E. coli or Streptomy-
ces, 125 mMHEPES pH 7.5, 20 mM DTT, 20% glycerol, 200 mM KCl,
0.16 mg/ml calf thymus DNA in a final volume of 12.5–25 ml. The
mixture was incubated at room temperature for 10 min, then 2–4 ml of
loading dye (50%(v/v) glycerol, 0.25% (w/v) bromophenol blue, 10 mM
Tris–HCl, pH 8, 1 mM EDTA) was added. To detect the binding of the
receptor to the butyrolactones, the butyrolactones can be added either
before or 10 min after the incubation. In the case of SCB1, 1 mg was
added to see a release of the full shift.
Note:
 For the E. coli crude extract, a 10 ml LB overnight preculture of E. coli
harboring a plasmid with the g-butyrolactone receptor gene under the
control of the lacZ promoter was inoculated at a 1:100 dilution in
50 ml LB and grown at 37 C until OD600 0.7–0.8 when induced with
1 mM (final conc.) IPTG (Isopropyl b-D-1-thiogalactopyranoside).
After another 3 h of incubation, cells were harvested by centrifugation
and the cell pellet was washed twice with buffer (50 mM of Tris pH
7.0, 1 mM of EDTA, 1 mM of DTT, 100 mM of phenylmethylsulfo-
nylfluoride (PMSF)) and resuspended in 500 ml of the same buffer.
100 ml aliquots were stored at 80 C for later use. For crude extract
154 Nai-Hua Hsiao et al.preparation, the cells were immediately disrupted by sonication. The
cell lysate was clarified by centrifugation and the supernatant used as a
crude extract after determination of the total protein content.
 For the S. coelicolor crude extract, S. coelicolor was grown in 50 ml of
SMM then the same procedure as above was followed except the cells
were resuspended in 100 ml prior to sonication and 10 ml was used for
the gel retardation analysis. Due to the growth phase-dependent
expression of ScbR, the time point of growth when the cells were
harvested is crucial to detect any protein binding to the DNA.
 KCl was the best salt for this assay and MgCl was not suitable.
4. For detection of 100–300 bp DNA fragments, a 5% acrylamide gel
(5% acrylamide: bisacrylamide ¼ 37.5:1, 1.25 ml of 10 TBE, 15 ml of
TEMED, 87.5 ml of 10% AMPS in a total of 12.5 ml) was used in 1
TBE (90 mM Tris–HCl, 90 mM boric acid, 2 mM EDTA, pH 8.0)
running buffer. It is also possible to use a 3.5% acrylamide gel to
detect a longer DNA fragment. A Bio-Rad Mini Protean kit was used
for running the gel at 100 V constant for 1 h till the BPB just ran off
the gel.
5. The gel was then taken off the glass and wrapped in cling film (Saran
wrap) and directly placed onto an X-ray film (Super RX (Fujifilm)), and
exposed for 30 min at room temperature in a cassette. The film was
developed using an automated film developer (Fig. 6.7A).Probes
Crude extract
R 2.5 ng DIG-X 0.23ng
4.0ml−
A B C D
130mg− − 130mg − 50mg
DIG-L 1.8 ng Cy 20ng
Figure 6.7 Gel retardation assay using differently labeled probes. Gel retardation
using: (A) Radio-labeled probes (R); (B) DIG-labeled probes with detection using
X-ray film (DIG-X); (C) DIG-labeled probes with detection using Lumi-imager
(DIG-L); (D) Cy3-labeled probes (Cy). All probes were made using a 146 bp DNA
fragment which includes the ScbR binding site Rwhich is situated at 68 to 42 nt
from the transcriptional start site (Takano et al., 2001).The amount of each probe used is
indicated next to each probe name. Crude extract (given in total protein as microl,
microg) from E. coli harboring pIJ6120 was used and the amount is indicated on the top
of the lanes.
g-Butyrolactone Extraction, Bioassay, and Gel Retardation Analysis 1557.1.2. DIG-labeled probes
1. DNA fragments were first amplified by PCR using both unlabeled-
oligos using the PCR conditions mentioned in Point 2 of Section
7.1.1. Purified PCR product (either by a cleanup kit or by extracting
from a gel), 100 ng, was used in the DIG gel shift kit 2nd generation
(Roche) labeling procedure, steps 5–7 (p11 of Roche protocol). (Note:
this kit labels 30 ends.)
2. After labeling, the probes were incubated with the protein for gel
retardation assays as in Point 3 of Section 7.1.1.
Note:
 The labeled probes can be stored at 20 C for a very long time.
 Depending on the sensitivity of the detection method used (see
below), the amount of DIG-labeled probe may have to be varied.
In our case, eightfold less probe was used for detection with X-ray
films (we used 1.8 ng of labeled probe) compared to when a Lumi-
imager F1 (we used 0.23 ng labeled probe) was used for detection
(Fig. 6.7B and C).
 After optimization of the amount of probe used, the protein concen-
tration in the assay will have to be adjusted to keep the protein/DNA
ratio constant.
3. After running, the gel was taken off the glass plates for direct contact-
blotting (Roche protocol 3.7.2), further crosslinking (3.7.3), and chemi-
luminescent detection (3.8). The membrane was detected using an X-ray
film exposed for 20 min, then developed in an automated X-ray film
developer (Fig. 6.7B) or in a Lumi-imager F1 (Roche) for 40 min at
room temperature (Fig. 6.7C).7.1.3. Cy3-labeled probes
The DIG-labeling protocol will take up to 2 days. To improve the effi-
ciency in time, Cy3-labeled oligos are now our preferred choice.
A preliminary protocol is described below.
1. 50-Cy3-labeled oligo was purchased from Sigma–Aldrich and used for
PCR along with the unlabeled-oligo as in Point 3 of Section 7.1.1. The
amplified product was purified and the concentration measured by
Nanodrop (Thermo scientific).
2. The gel retardation was conducted with 20 ng of Cy3-labeled DNA
fragment with 50–300 mg of crude extracts from Streptomyces as in Points
3 and 4 of Section 7.1.1. After running, the gel with the glass plate is
exposed for 30 s and detected in a LAS 4000 (Fujifilm) (Fig. 6.7D).
Note: A flourescence compound was detected in the Streptomyces crude
extract which may interfere with detection.
156 Nai-Hua Hsiao et al.8. Conclusions
The rapid small-scale purification of the g-butyrolactones and the
kanamycin assay have simplified the detection of the g-butyrolactones,
which are found to be one of the important factors in the regulation of
antibiotic production. From genome sequences and also from the sequence
of many antibiotic biosynthetic gene clusters many homologues to the
g-butyrolactone synthases and receptors have been identified, but the
number of g-butyrolactones elucidated has not increased since year 2000.
This method may provide an easy solution to detect the g-butyrolactones
from those strains which have the synthase and receptor homologues
and also to identify new organisms that may produce g-butyrolactones.
The binding sensitivity of the different g-butyrolactones to ScbR has been
tested and found to be lower; however, with enough material kanamycin
resistance was observed (Hsiao et al., submitted). Identification of the
receptor target is a major job. However, with the several hints obtained
from previous work and also from our experience with the gel retardation
assays, it may be possible to quicken the procedure.ACKNOWLEDGMENTS
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